Thus, anti-Ro52/TRIM21 was found to be significantly associated with lymphopenia, independently of the therapeutic regime, whereas patients with anti-SSA/Ro60 antibodies showed higher platelet numbers and lower haemoglobin levels than negative patients. Here, CALR is linked to lymphopenia.